Novartis India Ltd 500672
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹1,162.65
- Day Range
- ₹1,111.30–1,160.05
- 52-Week Range
- ₹599.95–1,248.00
- Bid/Ask
- ₹0.00 / ₹0.00
- Market Cap
- ₹27.63 Bil
- Volume/Avg
- 10,353 / 13,029
Key Statistics
- Price/Earnings (Normalized)
- 34.65
- Price/Sales
- 8.61
- Dividend Yield (Trailing)
- 2.15%
- Dividend Yield (Forward)
- 2.15%
- Total Yield
- 2.15%
Company Profile
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company operates in a single business segment namely Pharmaceutical Business, Its Pharmaceutical business focuses on Bone and Pain, Transplantation Immunology, and Neurosciences.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 62
- Website
- https://www.novartis.com
Comparables
Valuation
|
Metric
|
500672
|
506820
|
543434
|
|---|---|---|---|
Price/Earnings (Normalized) | 34.65 | 142.43 | 34.56 |
Price/Book Value | 3.86 | 25.92 | 5.81 |
Price/Sales | 8.61 | 13.23 | 8.09 |
Price/Cash Flow | 27.55 | 118.08 | 36.48 |
Price/Earnings
500672
506820
543434
Financial Strength
|
Metric
|
500672
|
506820
|
543434
|
|---|---|---|---|
Quick Ratio | 4.05 | 1.89 | 2.47 |
Current Ratio | 4.45 | 2.61 | 5.17 |
Interest Coverage | 46.30 | 87.81 | 51.09 |
Quick Ratio
500672
506820
543434
Profitability
|
Metric
|
500672
|
506820
|
543434
|
|---|---|---|---|
Return on Assets (Normalized) | 8.96% | — | — |
Return on Equity (Normalized) | 11.20% | — | — |
Return on Invested Capital (Normalized) | 6.06% | — | — |
Return on Assets
500672
506820
543434
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Dwywrpwscs | Ynb | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Cdrkycrkg | Zwgqz | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Wgqjjwlc | Jvyt | $48.4 Bil | |||
| Viatris Inc
VTRS
| Ddtqsccj | Mtlld | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Vqdvdpjy | Tmdn | $13.5 Bil | |||
| Catalent Inc
CTLT
| Xqlzjcrtk | Fbzmvr | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Qdrtylkl | Rrjypq | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Rylxrkhff | Fmhsf | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Lrwrxkprjm | Qcw | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Cllljrflz | Nmmh | $2.3 Bil |
United States